Evidence map›Paper›PMID 33243267›Full record

ArticleBMC medicine2020

A serological framework to investigate acute primary and post-primary dengue cases reporting across the Philippines.

Joseph R Biggs, Ava Kristy Sy, Oliver J Brady, Adam J Kucharski, Sebastian Funk, Mary Anne Joy Reyes, Mary Ann Quinones, William Jones-Warner, Yun-Hung Tu, Ferchito L Avelino and 15 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 4 countries.

Joseph R BiggsDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. Joseph.Biggs1@lshtm.ac.uk.ORCID 0000-0001-7273-874X
Ava Kristy SyDepartment of Virology, Research Institute for Tropical Medicine, Manila, Philippines.
Oliver J BradyDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Adam J KucharskiDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Sebastian FunkDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Mary Anne Joy ReyesDepartment of Virology, Research Institute for Tropical Medicine, Manila, Philippines.
Mary Ann QuinonesDepartment of Virology, Research Institute for Tropical Medicine, Manila, Philippines.
William Jones-WarnerDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Yun-Hung TuDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Ferchito L AvelinoPhilippine Epidemiology Bureau, Department of Health, Manila, Philippines.
Nemia L SucalditoPhilippine Epidemiology Bureau, Department of Health, Manila, Philippines.
Huynh Kim MaiPasteur Institute of Nha Trang, Nha Trang, Vietnam.
Le Thuy LienPasteur Institute of Nha Trang, Nha Trang, Vietnam.
Hung Do ThaiPasteur Institute of Nha Trang, Nha Trang, Vietnam.
Hien Anh Thi NguyenNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Dang Duc AnhNational Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Chihiro IwasakiPaediatric Infectious Diseases Department, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Noriko KitamuraPaediatric Infectious Diseases Department, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Lay-Myint YoshidaPaediatric Infectious Diseases Department, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Amado O TandocDepartment of Virology, Research Institute for Tropical Medicine, Manila, Philippines.
Eva Cutiongco-de la PazInstitute of Human Genetics, National Institute of Health, University of the Philippines, Manila, Philippines.
Maria Rosario Z CapedingDengue Study Group, Research Institute for Tropical Medicine, Manila, Philippines.
Carmencita D PadillaInstitute of Human Genetics, National Institute of Health, University of the Philippines, Manila, Philippines.
Julius Clemence R HafallaDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Martin L HibberdDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBResearch Institute for Tropical Medicine · PHInstitute of Vaccine and Medical Biologicals · VNNagasaki University · JPDepartment of Health · PHNational Institute Of Hygiene And Epidemiology · VNUniversity of the Philippines Manila · PH

Funding

Royal Society CHG\R1\170061Wellcome Trust 206250/Z/17/ZWellcome Trust 206471/Z/17/Z
6 · The paper itself

Abstract

backgroundIn dengue-endemic countries, targeting limited control interventions to populations at risk of severe disease could enable increased efficiency. Individuals who have had their first (primary) dengue infection are at risk of developing more severe secondary disease, thus could be targeted for disease prevention. Currently, there is no reliable algorithm for determining primary and post-primary (infection with more than one flavivirus) status from a single serum sample. In this study, we developed and validated an immune status algorithm using single acute serum samples from reporting patients and investigated dengue immuno-epidemiological patterns across the Philippines.

methodsDuring 2015/2016, a cross-sectional sample of 10,137 dengue case reports provided serum for molecular (anti-DENV PCR) and serological (anti-DENV IgM/G capture ELISA) assay. Using mixture modelling, we re-assessed IgM/G seroprevalence and estimated functional, disease day-specific, IgG:IgM ratios that categorised the reporting population as negative, historical, primary and post-primary for dengue. We validated our algorithm against WHO gold standard criteria and investigated cross-reactivity with Zika by assaying a random subset for anti-ZIKV IgM and IgG. Lastly, using our algorithm, we explored immuno-epidemiological patterns of dengue across the Philippines.

resultsOur modelled IgM and IgG seroprevalence thresholds were lower than kit-provided thresholds. Individuals anti-DENV PCR+ or IgM+ were classified as active dengue infections (83.1%, 6998/8425). IgG- and IgG+ active dengue infections on disease days 1 and 2 were categorised as primary and post-primary, respectively, while those on disease days 3 to 5 with IgG:IgM ratios below and above 0.45 were classified as primary and post-primary, respectively. A significant proportion of post-primary dengue infections had elevated anti-ZIKV IgG inferring previous Zika exposure. Our algorithm achieved 90.5% serological agreement with WHO standard practice. Post-primary dengue infections were more likely to be older and present with severe symptoms. Finally, we identified a spatio-temporal cluster of primary dengue case reporting in northern Luzon during 2016.

conclusionsOur dengue immune status algorithm can equip surveillance operations with the means to target dengue control efforts. The algorithm accurately identified primary dengue infections who are at risk of future severe disease.

Indexed as

AdolescentAdultChildChild, PreschoolCross-Sectional StudiesDengueDengue VirusFemaleHumansMalePhilippinesYoung AdultDengueFlavivirusImmuno-epidemiologyPhilippinesPost-primaryPrimarySerologySurveillance

Identifiers

PMID33243267
PMCPMC7694902
OpenAlexW3107557126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.